News Actemra Approved for Treatment of Hospitalized COVID-19 Patients Publish Date December 21, 2022 Actemra (tocilizumab) is an interleukin-6 receptor antagonist.
News FDA Authorizes Emergency Use of Kineret for Certain Hospitalized COVID-19 Patients Publish Date November 9, 2022 Kineret is an interleukin-1 receptor antagonist.